Literature DB >> 2418684

Maternal serum alpha-fetoprotein and fetal autosomal trisomies.

T A Doran, K Cadesky, P Y Wong, C Mastrogiacomo, T Capello.   

Abstract

Maternal serum alpha-fetoprotein values in 61 patients with fetal autosomal trisomies diagnosed at 6581 genetic amniocenteses were significantly lower than those in an equal number of matched control subjects. The genetic risk of fetal autosomal trisomies for women less than age 35 offered amniocentesis with maternal serum alpha-fetoprotein values less than 0.5 multiples of the median is in the same range as that currently accepted for advanced maternal age. Maternal serum alpha-fetoprotein screening for autosomal trisomies (mainly Down syndrome) is feasible.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2418684     DOI： 10.1016/0002-9378(86)90655-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  10 in total

1.  Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes.

Authors:  W L Kuo; H Tenjin; R Segraves; D Pinkel; M S Golbus; J Gray
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

2.  Gestational age at maternal serum alpha-fetoprotein screening and the detection of Down syndrome.

Authors:  K Waller; L Lustig; E Hook
Journal:  Am J Hum Genet       Date:  1990-09       Impact factor: 11.025

3.  Screening for maternal serum alpha-fetoprotein: what about the low side?

Authors:  A Lippman; J A Evans
Journal:  CMAJ       Date:  1987-04-15       Impact factor: 8.262

4.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

5.  Collagen and fibronectin synthesis by trisomic and triploid fibroblasts from human spontaneous abortuses.

Authors:  A A Delvig; V I Kukharenko; V M Belkin; V I Mazurov; K N Grinberg; S S Debov
Journal:  Mol Gen Genet       Date:  1987-10

Review 6.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 7.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 8.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 9.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 10.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.